Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Broadcom and Google Cloud Announce License Portability Support for VMware Cloud Foundation on Google Cloud VMware Engine
-
Asia Broadband Confirms Mining Title Registry Update for the La Paz Gold Mine Project in Etzatlan, Mexico, As Drilling Program Continues
-
TimeProvider® 4500 Series is the Industry’s First Grandmaster to Provide High-Speed Network Interfaces up to 25 Gbps
-
Great Lakes Reports Fourth Quarter and Full Year 2023 Results
-
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
-
IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology
-
XWELL Advances Expansion Plan Outside the Airport with Three New Naples Wax and Skin Care Locations
-
Ron Estep Appointed AVP, Contract Operations for Greater Hampton Roads Area
-
ToughBuilt Industries Announces Pricing of $3.5 Million Public Offering
-
Provident Welcomes Tom Mathew, First Vice President, Deputy Compliance Officer
-
Carbon Revolution Announces Preliminary Fiscal Second Quarter Results
-
Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services
-
10 Barrel Brewing Launches Pub Ice: a Refreshing Twist on ‘Cheap Fun’
-
Tyton Partners Promotes Catherine Shaw, Kate Sutherland, and Shlomy Kattan to Managing Director
-
The Vita Coco Company to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
-
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
-
Transparent Energy Records 14th Consecutive Year of Organic Annual Revenue Growth, Establishes Broad Transactional Expertise in Renewable-Energy Procurement
-
DCCA AWARDED $37 MILLION CONTRACT FROM DEFENSE INFORMATION SYSTEMS AGENCY
-
Live Oak Ventures Participates in Financing of Anatomy Financial
-
Lilium Announces FY and Q4 2023 Shareholder Letter and Webcast on February 27, 2024
-
Image Protect, Inc. Announces Nine Month Total Debt Reduction of $1,945,860
-
Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials
-
First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allogeneic INKT Cell Therapy and Agenus’ Botensilimab and Balstilimab
-
Alkami to Announce Fourth Quarter 2023 Financial Results
-
Lulus to Report Fourth Quarter and Full Year 2023 Results on March 6, 2024
-
Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer
-
BBSI Sets Fourth Quarter and Full Year 2023 Conference Call for Wednesday, February 28, 2024, at 5:00 p.m. ET
-
GCM Grosvenor to Present at the UBS Financial Services Conference on February 28, 2024
-
Kyivstar and Come Back Alive Raise UAH180M to Demine Ukraine, Reaching Campaign Target
-
HEULIEZ secures contract to supply 200 e-buses to Marseille
-
NANO Nuclear Energy to Present and Exhibit at Innovation Zero 2024, the UK’s Largest Net Zero Conference
-
ZyVersa Therapeutics Highlights Review Article Substantiating That Inflammasome Activation Is Pathogenic in Multiple Neurological Diseases
-
Clubhouse Media Group, Inc. Announces Miss Global Contestant, Patricia Rath, Joins HoneyDrip.com
-
“Strategic, deliberate” approach key to Canada’s international knowledge partnerships
-
BLINK CHARGING ANNOUNCES PRELIMINARY FULL-YEAR 2023 REVENUE IN EXCESS OF $140 MILLION, REITERATES ADJUSTED EBITDA PROFITABILITY TARGET
-
Kornit Digital Reports Fourth Quarter and Full Year 2023 Results
-
Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
-
Evoke Pharma Announces Closing of $7.5 Million Public Offering
-
CNH Industrial N.V. Reports Fourth Quarter and Full Year 2023 Results
-
Midland Provides an Overview of Its 2024 Exploration Activities With Its Partners and Also Follow-Up on Its New Discoveries
-
Medicenna Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Corporate Update
-
Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2023 Earnings and Company Updates
-
Sekur Private Data Ltd. Launches Small Business Solutions Marketing Efforts Amid Increased Attacks on SMBs in the USA During Election Year
-
Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s Disease
-
CoreCard Corporation Reports Fourth Quarter and Full Year 2023 Results
-
Conduent Recognized as a 2024 Leader in HR Benefits Administration by NelsonHall
-
DSM: Net Asset Value(s)
-
SFL - Fourth Quarter 2023 Results
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Alliance Trust PLC - Net Asset Value
